Christoph B. Olivier: Rapid Platelet Inhibition in Acute Coronary Syndromes
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Heart Journal. Acute Cardiovascular Care:
“I am glad to share our upcoming paper ‘Injectable antiplatelet therapies in acute coronary syndromes: Current status and Emerging Therapies’.
This review provides a complete overview of parenteral antiplatelet management in ACS:
Parenteral P2Y12 inhibitors and GPIIb/IIIa inhibitors: Instantaneous platelet inhibition when oral route absorption is delayed or unviable.
Pre-hospital administration: Potential clinical benefits of early subcutaneous candidates.
Clinical decision-making: Practical timing, dosing strategies, and safety considerations in acute settings.
Proud to work alongside first author Uwe Zeymar and all the co-authors Sogol Koolaji, Diego Araiza Garaygordobil,Peter Clemmensen, Mario Gramegna , Konstantin Krychtiuk, Andrea Rubboli, Benedikt Schrage, Christophe Vandenbriele, Kurt Huber and Diana Gorog.”
Title: Injectable antiplatelet therapies in acute coronary syndromes: Current status and Emerging Therapies. A position paper of the Task Force of Antithrombotic therapy of the ACVC
Authors: Uwe Zeymer, Sogol Koolaji, Diego Araiza-Garaygordobil, Peter Clemmensen, Mario Gramegna, Konstantin A Krychtiuk, Christoph B Olivier, Andrea Rubboli, Benedikt Schrage, Christophe Vandenbriele, Kurt Huber, Diana A Gorog
Other posts featuring Christoph B. Olivier on Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day